Dapoxetine – (119356-77-3)

Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation (PE) in men aged 18 to 64.

It works by inhibiting the serotonin transporter, increasing serotonin’s action at the postsynaptic cleft, and promoting ejaculatory delay. Unlike other SSRIs, dapoxetine is rapidly absorbed and eliminated, making it suitable for on-demand use.

Originally developed as an antidepressant by Eli Lilly, it was later repurposed for PE and sold to Johnson & Johnson.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Dapoxetine
https://pubchem.ncbi.nlm.nih.gov/compound/Dapoxetine
https://www.medchemexpress.com/Dapoxetine-hydrochloride.html?srsltid=AfmBOoqEhjpXaHCBk5UYUFNSRaCS6jEUFrf1cgHqz0pR0Moc0t6tDR5q
https://www.medkoo.com/products/44641
https://go.drugbank.com/drugs/DB04884